Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ABOS


Fundamental

Company: Acumen Pharmaceuticals Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -1.37
Insider Own: 25.05%
Shs Outstand: 60.08M
Perf Week: -8.87%
Market Cap: 114.24M
Forward P/E: -
EPS next Y: -1.86
Insider Trans: 0.00%
Shs Float: 45.03M
Perf Month: -21.94%
Income: -81.67M
PEG: -
EPS next Q: -0.49
Inst Own: 64.39%
Short Float: 3.08%
Perf Quarter: -21.94%
Sales: 0.00M
P/S: -
EPS this Y: -46.30%
Inst Trans: 0.36%
Short Ratio: 6.03
Perf Half Y: -17.41%
Book/sh: 3.62
P/B: 0.51
EPS next Y Percentage: -17.59%
ROA: -29.52%
Short Interest: 1.39M
Perf Year: -39.94%
Cash/sh: 3.24
P/C: 0.57
EPS next 5Y: -
ROE: -32.83%
52W Range From: 1.72
52W Range To: 5.09
Perf YTD: -51.82%
Dividend Est.: -
P/FCF: -
EPS past 5Y: -54.03%
ROI: -33.06%
52W High: -63.65%
Beta: 0.01
Dividend TTM: -
Quick Ratio: 10.43
Sales past 5Y: -28.84%
Gross Margin: -
52W Low: 7.87%
ATR (14): 0.16
Dividend Ex-Date: -
Current Ratio: 10.43
EPS Y/Y TTM: -23.23%
Oper. Margin: -
RSI (14): 32.26
Volatility W: 7.61%
Volatility M: 6.73%
Employees: 52
Debt/Eq: 0.14
Sales Y/Y TTM: -
Profit Margin: -
Recom: 1.00
Target Price: 12.00
Option/Short: Yes / Yes
LT Debt/Eq: 0.14
EPS Q/Q: -107.37%
Payout: -
Rel Volume: 4.33
Prev Close: 1.80
Sales Surprise: -
EPS Surprise: -38.24%
Sales Q/Q: -
Earnings: Nov 12 BMO
Avg Volume: 229.85K
Price: 1.85
SMA20: -13.35%
SMA50: -25.63%
SMA200: -36.19%
Trades:
Volume: 995,292
Change: 2.78%

Technical:


Latest News:

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference somewhat bullish
ABOS

Summary: Acumen Pharmaceuticals, Inc. will participate in a fireside chat at the Bank of America CNS Therapeutics Virtual Conference on October 7, 2024.

Full article
2024-09-30T20:18:31Z
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference neutral
ABOS

Summary: Acumen Pharmaceuticals, Inc. will participate in a fireside chat at the 2024 Bank of America Healthcare Conference to discuss their novel therapeutic for Alzheimer’s disease.

Full article
2024-05-09T11:36:06Z
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference neutral
ABOS

Summary: Acumen Pharmaceuticals, Inc. will participate in a fireside chat at the 2024 Bank of America Healthcare Conference to discuss their novel therapeutic for Alzheimer's disease.

Full article
2024-05-08T22:08:56Z